Phase II study of fludarabine, cytarabine (ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders

Leukemia and Lymphoma

Volumn 43, Issue 4, 2002, Pages 767-772

  Tsimberidou, Apostolia M ^a   O'Brien, Susan M ^a   Cortes, Jorge E ^a   Faderl, Stefan ^a   Andreeff, Michael ^a   Kantarjian, Hagop M ^a   Keating, Michael J ^a   Giles, Francis J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Fludarabine containing regimens; LPD; Refractory lymphoma; Richter's syndrome

Indexed keywords

ACICLOVIR; CISPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FEVER; GRANULOCYTOPENIA; HEART FAILURE; HERPES SIMPLEX VIRUS; HUMAN; HYPERBILIRUBINEMIA; HYPERCALCEMIA; HYPERURICEMIA; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPONATREMIA; IMMUNOBLAST; LEUKEMIA REMISSION; LEUKOPENIA; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT TRANSFORMATION; MYCOSIS; NEUTROPHIL; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; REFRACTORY PERIOD; RICHTER SYNDROME; THROMBOCYTOPENIA; TREATMENT FAILURE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, LARGE-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; VIDARABINE;

EID: 0036239496     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290016872     Document Type: Article

References (36)

1. "Chronic lymphocytic leukemia in (Richter's) transformation"
2. "Richter's syndrome: A report on 39 patients"
3. "Fludarabine: A new agent with major activity against chronic lymphocytic leukemia"
4. "Fludarabine phosphate in the treatment of chronic lymphocytic leukemia"
5. "Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia"
6. "Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis"
7. "Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia"
8. "Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen"
9. "Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma"
10. "Fludarabine-based chemotherapy in untreated mantle cell lymphomas: An encouraging experience in 29 patients"
11. "Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): Results of a phase II study of the German CLL Study Group"
12. "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: Results and long-term follow-up-a report from the Eastern Cooperative Oncology Group"
13. "Experience with salvage regimens at M.D. Anderson Hospital"
14. "Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia"
15. "Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: Implications for a continuous infusion schedule"
16. "Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study"
17. "Fludarabine, cisplatin and ara-C: An active regimen in patients with anthracyclin-refractory intermediate-grade non-Hodgkin's lymphoma"
18. "A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia"
19. "Evaluating treatment strategies in chronic lymphocytic leukemia: Use of quality-adjusted survival analysis"
20. "Achieving optimal outcomes in chronic lymphocytic leukaemia"
21. "Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma"
22. "Non-Hodgkin's lymphoma: Pathogenesis, clinical presentation, and treatment"
23. "Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation"
24. "Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants"
25. "Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: A retrospective analysis"
26. "New perspectives on the approach to chronic lymphocytic leukemia"
27. "Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta"
28. "Differentiation of purified malignant B cells induced by PMA or by activated normal T cells"
29. "Cytogenetic abnormalities in chronic lymphocytic leukemia"
30. "Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis"
31. "Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoxome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome"
32. "The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells"
33. "Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia"
34. "The rapamycin-sensitive signal transduction pathway as a target for cancer therapy"
35. "The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function"
36. "BCL-2 antisense therapy in patients with non-Hodgkin lymphoma"